Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 2176 AL 2190

The Role of the Ganglion Cell Layer as an OCT Biomarker in Neurodegenerative Diseases

Ruggeri F, Fumi D, Bassis L, Pippo MD, Abdolrahimzadeh S.

J Integr Neurosci. 2025 May 23;24(5):26039. doi: 10.31083/JIN26039.

LRP1 at the crossroads of Parkinson's and Alzheimer's: Divergent roles in α-synuclein and amyloid pathology

Alshahrani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Kadasah SF, Alexiou A, Papadakis M, El-Saber Batiha G.

Eur J Pharmacol. 2025 Sep 5;1002:177830. doi: 10.1016/j.ejphar.2025.177830. Epub 2025 Jun 6.

The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis

Fołta J, Rzepka Z, Wrześniok D.

Int J Mol Sci. 2025 May 28;26(11):5177. doi: 10.3390/ijms26115177.

A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap

Lau VZ, Awogbindin IO, Frenkel D, Whitehead SN, Tremblay MÈ.

Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.

The cognitive and neurological implications of toxoplasma gondii infection: Evidence from a systematic review and meta-analysis

Kavakebian M, Ghandali T, Nasiri H, Ramezani-Moghadam F, Alizadeh S, Alizadeh S, Silakhor M, Rajabi M, Mirmazhari A, Asgarian P, Rahimi H, Karimi M, Moosazadeh M.

Acta Trop. 2025 Aug;268:107705. doi: 10.1016/j.actatropica.2025.107705. Epub 2025 Jun 21.

Advancing Amyloid Aggregation Research: A Focus on Innovative Therapies, Molecular Modeling and Nano-Delivery Systems in Alzheimer's Disease

Hasan U, Jain H, Ali R.

Curr Drug Targets. 2025;26(11):779-798. doi: 10.2174/0113894501388678250618070927.

Targeting the redox neuroinflammatory nexus: insights into Alzheimer's and Parkinson's diseases

Dharshini LCP, Sakthivel KM, Rex KGR, Rasmi RR.

Inflammopharmacology. 2025 Jul;33(7):3885-3895. doi: 10.1007/s10787-025-01831-w. Epub 2025 Jul 2.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives

Jeong YJ, Lee HJ, Kim JS, Kim SJ, Jo U, Park JY, Jun SJ, Lee WS, Song M, Kim D, Cho G, Song JH, Hoe HS.

Med Res Rev. 2026 Jan;46(1):316-327. doi: 10.1002/med.70005. Epub 2025 Jul 31.

Next-generation CRISPR gene editing tools in the precision treatment of Alzheimer's and Parkinson's disease

Meshram HK, Gupta SK, Gupta A, Nagori K, Ajazuddin.

Ageing Res Rev. 2025 Sep;111:102851. doi: 10.1016/j.arr.2025.102851. Epub 2025 Aug 5.

Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's

Jeyabalan JB, Pandi A V, Veintramuthu S, Sivasamy R, Dhanasekaran M, Justin A.

Neurol Sci. 2025 Oct;46(10):4779-4789. doi: 10.1007/s10072-025-08421-2. Epub 2025 Aug 26.

Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer's disease and Parkinson's disease

Liu Y, Zhang J, Tang L, Yang J, Hao L, Lou F, Su J.

Arch Toxicol. 2025 Dec;99(12):4709-4735. doi: 10.1007/s00204-025-04174-1. Epub 2025 Aug 28.

Language dysfunction as a primary feature of cognitive decline in neurological populations

Leavitt VM, Simani L, Haghighi AB, Koch M, König A, Rusz J.

J Neural Transm (Vienna). 2026 Mar;133(3):397-407. doi: 10.1007/s00702-025-03015-w. Epub 2025 Sep 6.

Effects of monoclonal antibody therapies on depression in Parkinson's disease and Alzheimer's disease: Systematic review and meta-analysis

Gitlin-Leigh G, Wilson J, Howard R, Howard R, Costello H.

J Alzheimers Dis. 2025 Nov;108(2):500-508. doi: 10.1177/13872877251378156. Epub 2025 Sep 19.

Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review

Liu RY, Yin KF, He SY, Su WM, Duan QQ, Wen XJ, Chen T, Shen C, Li JR, Cao B, Chen YP.

Transl Psychiatry. 2025 Oct 10;15(1):388. doi: 10.1038/s41398-025-03639-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias